Therapeutic targeting of integrin αvβ6 in breast cancer. - Wikidata - wikimedia - TriplyDB

Therapeutic targeting of integrin αvβ6 in breast cancer.

Therapeutic targeting of integrin αvβ6 in breast cancer.

http://www.wikidata.org/entity/Q34120685

about

Tumour Cell Heterogeneity The role of integrins in TGFβ activation in the tumour stroma The complexity of integrins in cancer and new scopes for therapeutic targeting Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain.Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression.High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.Characterization of a P-Rex1 gene signature in breast cancer cells Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.Targeted therapies in breast cancer: New challenges to fight against resistance.Integrin αvβ6 sets the stage for colorectal cancer metastasis.HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression.Exploring the Role of RGD-Recognizing Integrins in Cancer.Integrins as Therapeutic Targets: Successes and Cancers.Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

P2860

Q26765895-C9B9514C-9183-4A32-A880-456FADDBF131 Q28068373-A48E68F7-F476-4F52-9D19-C0556D42BAF3 Q28073343-D104A941-1D7D-402E-A9FB-39073998304F Q33582972-7D6DA7AA-DD71-451D-87B0-6B87D7A07F3D Q34704914-74B3215B-0667-4AA7-AE65-8F7D3B17F712 Q35631181-A33F721D-6830-466E-9737-D16A996AAA4F Q35724081-834E736F-7FD7-4ED2-BDCD-67D23A582573 Q35783902-6A013D3F-433D-441D-A8A9-426076E9DB5B Q36918650-7D69F992-F8AF-41D8-917D-BF89AC54BA9B Q37588287-3058B349-510E-402B-9521-CB92288873B1 Q37603527-B5FB2B87-1677-4635-889F-442B0EE24C97 Q37743048-0098FEDA-A838-49C8-9A9A-05D98423CF24 Q38580357-A22C3C67-6EF9-43A2-B2F7-046983C5842D Q38710164-C7E9EC01-2986-4177-AC5C-9A306EF646D4 Q38923285-E6E1F442-5C7B-4B12-BA32-AD4C5F8ECF95 Q41670915-01174161-D400-4A9A-B2F5-8AFAAF859B15 Q41670949-F91DA1D8-3F8C-4A28-9574-BBDA1B485CB1 Q41892179-02B1890F-9749-495F-B6CE-0C5F744957F1 Q42516196-2145F86F-0D0A-48BB-8801-BD1ABC0716B5 Q47549552-66455874-EBEE-423B-9285-C03FD7C31A16 Q52659954-DA563A2E-5113-48E8-A6E1-48B50E0885FA Q53705802-A540F1C6-9A32-4038-B872-FDDF158F5F5A Q55312006-6FD8364E-A0DA-4171-91EA-5C718F7F173E

P2860

Therapeutic targeting of integrin αvβ6 in breast cancer.

http://www.wikidata.org/entity/Q34120685

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Therapeutic targeting of integrin αvβ6 in breast cancer.

@ast

Therapeutic targeting of integrin αvβ6 in breast cancer.

@en

Therapeutic targeting of integrin αvβ6 in breast cancer.

@nl

type

label

Therapeutic targeting of integrin αvβ6 in breast cancer.

@ast

Therapeutic targeting of integrin αvβ6 in breast cancer.

@en

Therapeutic targeting of integrin αvβ6 in breast cancer.

@nl

prefLabel

Therapeutic targeting of integrin αvβ6 in breast cancer.

@ast

Therapeutic targeting of integrin αvβ6 in breast cancer.

@en

Therapeutic targeting of integrin αvβ6 in breast cancer.

@nl

P1433

Q34120685-D11138B5-AB52-420E-8A3C-276CD8D9B43E

P1476

Q34120685-D6223AE8-D8E4-4F6C-84E4-BF65F7E74E43

P2093

Q34120685-01AB9534-E09E-4B97-B1AB-C08EFB3F8A89

Q34120685-0E90B5B6-2A00-4189-9AD6-0B2F54603A81

Q34120685-14A8106D-0536-48A2-A064-C996A5068434

Q34120685-1775E0FD-B120-4D8D-B4BF-77BC5D21AC26

Q34120685-4A601714-9DCD-4C41-A448-9CFE98089FED

Q34120685-5F2DFCC7-EEF7-46AD-934D-4BC2611D5519

Q34120685-6CBBED0E-29B5-44FE-A6FD-6D3F9061B3FB

Q34120685-71C714D4-5C81-401A-8E1F-10FFBDE9A84C

Q34120685-778D5981-871A-45E2-A6C9-9E87BF7DC779

Q34120685-8073D3C7-4A4F-4FCF-B0C5-E9312CB6A715

P2860

Q34120685-069E767E-1C43-4C4D-8AF3-A53CE9092C6B

Q34120685-148411F8-5345-489D-A861-C965717A88C1

Q34120685-155EE867-9597-4F11-BCD2-7F7F9BAD34D0

Q34120685-1976BEFE-C60F-4360-91B3-F86D9386E64A

Q34120685-1DDFC84B-F679-4238-BE19-7ADE27443697

Q34120685-1F830CBF-2A0C-413E-8ADB-CD3A4AFABDF0

Q34120685-239E49E5-929B-4F7D-832F-A3D111DC687D

Q34120685-27485820-576F-4956-BA0B-B914110CFA00

Q34120685-29052404-8974-4740-998B-B52792F3693A

Q34120685-347CF001-190D-40AD-9433-B79A93211858

P31

Q34120685-9D02781B-56E9-4799-B64B-B3009F1C0541

P356

Q34120685-85B701DA-3121-4F47-A57D-4B71816B46CA

P407

Q34120685-EAF81703-EDBC-44DD-BCC0-826CCB232B24

P433

Q34120685-C8A0DF22-B144-4E3A-A1FC-DE3C6FE3A0F5

P478

Q34120685-3F6821EB-85DB-49A9-A5A3-17CB9CA30FCA

P50

Q34120685-0013BFBD-097A-4E88-9670-9AC142D992A6

Q34120685-28B1552B-3CB4-4320-9A51-0A16ABD7C253

Q34120685-2BB4DEC8-E3A9-4C3F-91AF-12B176EE54C0

Q34120685-3D570E06-5BAB-4357-BF2D-723B8F3C35A9

Q34120685-491B0114-523C-4C32-B2E2-EF9FEBB70A29

Q34120685-E83B2E06-EBA8-4261-88EF-B47B364F3444

Q34120685-FD7DFF1A-9700-41CA-BF15-445125A28C14

P577

Q34120685-B01CF354-23F1-4044-9143-9C969921EA89

P5875

Q34120685-C354B237-9E45-402E-ACEB-DC6C66A21253

P698

Q34120685-1C247FCD-1A51-4BDE-87A7-FC14DDC7C148

P932

Q34120685-D7F56429-7461-4D0E-9AB4-717D31B2A174

P356

P1433

Journal of the National Cancer Institute

P1476

Therapeutic targeting of integrin αvβ6 in breast cancer.

@en

P2093

Alastair M Thompson

http://www.w3.org/2001/XMLSchema#string

Antonio Saha

http://www.w3.org/2001/XMLSchema#string

Cheryl Gillett

http://www.w3.org/2001/XMLSchema#string

Gareth J Thomas

http://www.w3.org/2001/XMLSchema#string

Ian R Hart

http://www.w3.org/2001/XMLSchema#string

J Louise Jones

http://www.w3.org/2001/XMLSchema#string

Jane Kendrew

http://www.w3.org/2001/XMLSchema#string

John F Marshall

http://www.w3.org/2001/XMLSchema#string

Kate M Moore

http://www.w3.org/2001/XMLSchema#string

Kellie Brouilette

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

Biology of HER2 and its importance in breast cancer.

P31

scholarly article

P356

10.1093/JNCI/DJU169

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Adam R Brentnall

Paul H. Weinreb

Andrew R. Green

P577

2014-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263475136

http://www.w3.org/2001/XMLSchema#string

P698

24974129

http://www.w3.org/2001/XMLSchema#string

P932

4151855

http://www.w3.org/2001/XMLSchema#string